Regulatory News
Wednesday, February 1, 2017
REFILE-Japan's Takeda committed to single-digit U.S. drug price rises
TOKYO, Feb 1 (Reuters) - Japan's largest drugmaker, Takeda
Pharmaceuticals Co, on Wednesday said it would maintain
its pricing model in the U.S. market, brushing off demands by
U.S. President Donald...
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment